Cargando…
Proteomics approaches to fibrotic disorders
This review provides an introduction to mass spectrometry based proteomics and discusses several proteomics approaches that are relevant in understanding the pathophysiology of fibrotic disorders and the approaches that are frequently used in biomarker discovery.
Autor principal: | Gucek, Marjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368766/ https://www.ncbi.nlm.nih.gov/pubmed/23259639 http://dx.doi.org/10.1186/1755-1536-5-S1-S10 |
Ejemplares similares
-
Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases
por: Piera-Velazquez, Sonsoles, et al.
Publicado: (2012) -
Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells
por: Thiele, Geoffrey M, et al.
Publicado: (2004) -
A neural network approach to multi-biomarker panel discovery by high-throughput plasma proteomics profiling of breast cancer
por: Zhang, Fan, et al.
Publicado: (2013) -
An automated proteomic data analysis workflow for mass spectrometry
por: Pendarvis, Ken, et al.
Publicado: (2009) -
PEPPI: a peptidomic database of human protein isoforms for proteomics experiments
por: Zhou, Ao, et al.
Publicado: (2010)